ArticleClinical proteomics2022

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line.

Stella K Vasiliou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.